Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,K11_CHOLELITH,Inverse variance weighted,122,1.06 [1.03-1.1],4.25273824340628e-05,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Wald ratio,1,1.27 [1.08-1.49],0.00383764322969551,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,K11_GALLBILPANC,Inverse variance weighted,21,1.09 [1.03-1.16],0.00521306041412462,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter V Mental and behavioural disorders,AUD,Inverse variance weighted,6,1.05 [1-1.11],0.0345835626759096,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,69,1.03 [1-1.06],0.0386170248247153,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter V Mental and behavioural disorders,F5_ALCOHOL_DEPENDENCE,Inverse variance weighted,3,1.05 [1-1.1],0.0486283208610478,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter X Diseases of the respiratory system,J10_LOWERINF,Wald ratio,1,0.77 [0.6-1],0.0486873118800863,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,14,1.03 [1-1.07],0.0834754426279304,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,Inverse variance weighted,11,1.05 [0.99-1.12],0.0859805087078493,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter V Mental and behavioural disorders,ALCOHOLMENTAL,Wald ratio,1,1.12 [0.98-1.27],0.101963376679153,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Wald ratio,1,1.16 [0.96-1.4],0.129468131059851,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Wald ratio,1,0.91 [0.81-1.03],0.142102228746906,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Wald ratio,1,1.21 [0.93-1.57],0.161792480321966,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,2,1.09 [0.96-1.22],0.172733091460496,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,13,1.03 [0.99-1.08],0.183094993050211,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Wald ratio,1,1.18 [0.92-1.51],0.183384749845907,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Wald ratio,1,1.22 [0.89-1.68],0.214955302183275,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,61,0.97 [0.93-1.02],0.220948902370994,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,16,1.04 [0.97-1.12],0.245369008894301,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,K11_DIAHER,Inverse variance weighted,8,0.97 [0.92-1.02],0.247618464099746,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,6,1.03 [0.98-1.07],0.255379009336392,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter II Neoplasms,C3_BILIARY_GALLBLADDER_EXALLC,Inverse variance weighted,3,1.02 [0.99-1.06],0.256654149008195,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,24,1.02 [0.99-1.05],0.286726036513129,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Wald ratio,1,0.97 [0.92-1.03],0.332001801483811,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,8,1.06 [0.94-1.21],0.33216662839207,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,K11_CROHN,Inverse variance weighted,3,1.02 [0.98-1.07],0.34389205965785,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Wald ratio,1,1.04 [0.96-1.12],0.368677439795997,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,24,1.03 [0.96-1.11],0.374227341702691,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter VI Diseases of the nervous system,G6_EPIPAROX,Inverse variance weighted,11,1.06 [0.92-1.23],0.412584669213636,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,Inverse variance weighted,2,1.08 [0.88-1.33],0.446412416943082,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,10,0.95 [0.84-1.08],0.452669849782131,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,K11_CD_NOUC,Inverse variance weighted,4,1.01 [0.98-1.04],0.48114871595243,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter X Diseases of the respiratory system,J10_RESPIRATORY,Inverse variance weighted,15,0.95 [0.83-1.09],0.486751334450947,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,2,0.82 [0.45-1.47],0.498558704112977,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Wald ratio,1,1.02 [0.96-1.07],0.562379419568289,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,35,1.01 [0.97-1.05],0.56359282483904,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter IX Diseases of the circulatory system,I9_PAD,Inverse variance weighted,2,1.02 [0.95-1.09],0.579878923583252,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Wald ratio,1,1.02 [0.94-1.12],0.589546842996521,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,4,0.97 [0.86-1.09],0.604642929856006,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Wald ratio,1,0.99 [0.96-1.03],0.617327121960277,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Wald ratio,1,0.92 [0.66-1.28],0.618303307490396,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,2,0.97 [0.84-1.11],0.61841783324029,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,2,0.99 [0.95-1.03],0.626808848877913,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,3,0.99 [0.93-1.05],0.65033661663566,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Wald ratio,1,0.98 [0.9-1.07],0.655804641603779,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Inverse variance weighted,3,0.99 [0.95-1.03],0.656138062711243,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,JOINTPAIN,Inverse variance weighted,3,0.97 [0.85-1.11],0.669149163259757,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter IX Diseases of the circulatory system,I9_HYPTENSPOR,Wald ratio,1,0.99 [0.96-1.03],0.674441767847273,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERANAEMIA,Wald ratio,1,0.95 [0.76-1.19],0.679850116941659,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,CHRONNAS,Inverse variance weighted,9,0.99 [0.96-1.02],0.685314157596528,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Wald ratio,1,0.96 [0.76-1.22],0.755012503385405,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,K11_DIVERTIC,Inverse variance weighted,50,1.01 [0.97-1.04],0.760362559424076,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,7,0.99 [0.92-1.06],0.761911371966096,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,NAFLD,Inverse variance weighted,6,1 [0.98-1.03],0.775287073955336,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_BLOOD_IMMUN,Wald ratio,1,0.95 [0.69-1.32],0.777837901776331,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Inverse variance weighted,21,1.01 [0.96-1.06],0.799502693333724,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,K11_CHOLANGI_STRICT,Wald ratio,1,1.01 [0.96-1.05],0.804659245542933,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,4,1.02 [0.89-1.16],0.805925948526033,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,5,1.01 [0.94-1.08],0.826825128689032,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,22,1 [0.96-1.05],0.833683844586849,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,3,0.97 [0.7-1.33],0.842078859239507,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,2,1 [0.97-1.04],0.899018681367733,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,K11_CD_STRICT2,Inverse variance weighted,8,1 [0.98-1.02],0.920469413121714,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_BCKGRND_RETINA,Inverse variance weighted,3,1 [0.96-1.04],0.939423230652749,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter X Diseases of the respiratory system,COPD_HOSPITAL_MAIN,Inverse variance weighted,7,1 [0.93-1.07],0.960635675567592,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,2,1 [0.86-1.17],0.960929173880058,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,K11_ALCOLIV,Inverse variance weighted,4,1 [0.95-1.06],0.97142504687378,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,2,1 [0.96-1.05],0.975221575663216,trans
BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Wald ratio,1,1 [0.64-1.55],0.993093407335968,trans
